Horizon Therapeutics' GAAP net income for 2021 was $534.491 million, up 37.1% from $389.796 million in the previous year. Revenue increased 46.6% to $3.226 billion, compared to $2.2 billion a year earlier.
Horizon Therapeutics' GAAP net income for 2021 was $534.491 million, up 37.1% from $389.796 million in the previous year. Revenue increased 46.6% to $3.226 billion, compared to $2.2 billion a year earlier. 
ir.horizontherapeutics.com
English (US) 